Geraldine Henwood, Director at MAP Pharmaceuticals, Inc. (MAPP), sold 10,000 shares at $25.00 ($250K) on 2013-02-28, disclosed to the SEC on 2013-03-04.
Scheduled sale ($250k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |